Skip to main content

COVID-19

Get the latest public health information from CDC

Get the latest research information from NIH | Español

NIH staff guidance on coronavirus (NIH Only)

You are here

News & Events

News Releases

20210318-dna.jpg

NIH leaders on the future of precision medicine, healthcare transformation

March 18, 2021 — Authors explain seven opportunities to accelerate tailored medicine efforts and create a more equitable health landscape in the future.
20210311-pregnancy-niehs.jpg

Preterm birth, prolonged labor influenced by progesterone balance

March 11, 2021 — Novel research in mice sheds light on hormone regulation needed in late pregnancy, opens door for therapy.
20210311-phage-niaid.jpg

NIH awards grants to support bacteriophage therapy research

March 11, 2021 — “Phage” therapies offer potential strategy to combat antibacterial resistance.
20210311-nei.jpg

NIH-led team sets new bar in retinal imaging

March 11, 2021 — By eliminating extraneous light, the scientists improved resolution by 33%.
20210310-polygenic.jpg

NIH researchers develop guidelines for reporting polygenic risk scores

March 10, 2021 — Researchers hope the new approach will be used as a framework for publishing studies on polygenic risk scores. .
20210310-mosquito.jpg

Study of mosquito protein could lead to treatments against life-threatening viruses

March 10, 2021 — Protein AEG12 strongly inhibits the family of viruses that cause yellow fever, dengue, West Nile, and Zika.
20210309-niaid-protein.jpg

NIH scientists use human cerebral organoid to test drug for deadly brain disease

March 9, 2021 — NIH, NIAID, scientists, human, cerebral organoid, test, drug, Creutzfeldt-Jakob disease.
20210308-coronavirus.jpg

Statement on NIH starting enrollment for third trial of blood clotting treatments for COVID-19

March 8, 2021 — Trial explores the use of the Eliquis® in patients who have been discharged from the hospital following a diagnosis of moderate-to-severe COVID-19.
20210304-covid.jpg

NIH-Sponsored ACTIV-3 Clinical Trial Closes Enrollment into Two Sub-Studies

March 4, 2021 — ACTIV-3 is a master protocol designed to allow for the study of multiple investigational agents compared to placebo in adults hospitalized with COVID-19.
20210304-mitochondria.jpg

NIH scientists discover how DNA fragments can trigger inflammation in sickle cell disease

March 4, 2021 — Finding could lead to new ways to reduce complications from painful red blood cell disorder.

Pages

Connect with Us